Evan Loh
2020
In 2020, Evan Loh earned a total compensation of $1.5M as Chief Executive Officer at Paratek Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $431,250 |
|---|---|
| Salary | $575,000 |
| Stock Awards | $505,440 |
| Other | $22,921 |
| Total | $1,534,611 |
Loh received $575K in salary, accounting for 37% of the total pay in 2020.
Loh also received $431.3K in non-equity incentive plan, $505.4K in stock awards and $22.9K in other compensation.
Rankings
In 2020, Evan Loh's compensation ranked 6,735th out of 13,090 executives tracked by ExecPay. In other words, Loh earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,735 out of 13,090 | 49th |
Division Manufacturing | 2,806 out of 5,621 | 50th |
Major group Chemicals And Allied Products | 1,134 out of 2,254 | 50th |
Industry group Drugs | 978 out of 1,954 | 50th |
Industry Pharmaceutical Preparations | 730 out of 1,459 | 50th |
Source: SEC filing on April 23, 2021.
Loh's colleagues
We found two more compensation records of executives who worked with Evan Loh at Paratek Pharmaceuticals in 2020.